Photo: Courtesy of Eli Lilly
The US Court of Appeals for the Federal Circuit has affirmed a ruling by a district court giving a win to Eli Lilly in a patent case against Teva.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Eli Lilly, Teva, patent, Alimta, Federal Circuit, chemotherapy